Alan Robert Ross - Comments
Contributor's Links: Trust Intelligence
I started trading cheap mining stocks as a Graduate Student in the Neureopsychology Lab of McGill's Allan Memorial Institute before the term "daytrading" was invented. In my spare time, I read everything on investing in the Business School library and I devoured their collection of ...more
Latest Comments
Provectus Phase III Melanoma Trial Results Earlier Than Planned?
8 years ago

Even more of a bargain at this point, but it is a waiting game for news. Q1'16 should see some, fundamental advance, although only time will tell market reaction.

In this article: PVCT
Provectus Phase III Melanoma Trial Results Earlier Than Planned?
9 years ago

Lots of things happening for Provectus and in a direction opposite the share price. Their Phase 3 trial has started and will be gaining momentum. See my latest, here: www.trustintelligence.com/.../viewtopic.php

New and probably stunningly good liver cancer data is due out in less than 6 weeks. Hints indicate that this will show efficacy that is way better than anything other drug available or in development. There are over a million people with liver cancer in the US. And with China having 55% of world primary liver cancer, the recently extended MOU with govt.-owned Sinopharm may soon be converted into an official license deal.

They just started talking with Brazil for a South American license and have a number of other deals they are working on. Should be a surprising summer for a stock that does not deserve to be so cheap!

In this article: PVCT
Provectus Phase III Melanoma Trial Results Earlier Than Planned?
9 years ago
You are welcome Kent. Hope you found the possibilities interesting. More to come.
In this article: PVCT
1 to 3 of 3 comments